Comparison of the pharmacokinetic profiles of three low molecular mass heparins - dalteparin, enoxaparin and nadroparin - administered subcutaneously in healthy volunteers (doses for prevention of thromboembolism)

Thrombosis and Haemostasis

Volumn 73, Issue 4, 1995, Pages 630-640

  Collignon, F ^a   Frydman, A ^a   Caplain, H ^a   Ozoux, M L ^a   Le Roux, Y ^a   Bouthier, J ^a   Thebault, J J ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; DALTEPARIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBIN TIME; THROMBOEMBOLISM; URINARY EXCRETION;

EID: 0028933964     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1653833     Document Type: Article

References (0)